Annual Operating Margin
-95.00%
+110.31%+53.73%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual operating profit margin is -95.00%, with the most recent change of +110.31% (+53.73%) on December 31, 2023.
- During the last 3 years, RVNC annual operating margin has risen by +1687.46% (+94.67%).
- RVNC annual operating margin is now at all-time high.
Performance
RVNC Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-53.87%
-1.08%-2.05%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly operating profit margin is -53.87%, with the most recent change of -1.08% (-2.05%) on September 30, 2024.
- Over the past year, RVNC quarterly operating margin has increased by +15.55% (+22.40%).
- RVNC quarterly operating margin is now -2.05% below its all-time high of -52.79%, reached on June 30, 2024.
Performance
RVNC Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
RVNC Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.7% | +22.4% |
| 3 y3 years | +94.7% | +85.4% |
| 5 y5 years | +97.5% | +99.9% |
RVNC Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.1% | -2.0% | +79.8% |
| 5 y | 5-year | at high | +99.8% | -2.0% | +100.0% |
| alltime | all time | at high | +99.8% | -2.0% | +100.0% |
Revance Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -53.87%(+2.0%) |
| Jun 2024 | - | -52.79%(-41.4%) |
| Mar 2024 | - | -90.16%(-12.0%) |
| Dec 2023 | -95.00%(-53.7%) | -102.48%(+47.6%) |
| Sep 2023 | - | -69.42%(-33.0%) |
| Jun 2023 | - | -103.55%(+1.5%) |
| Mar 2023 | - | -102.04%(-31.7%) |
| Dec 2022 | -205.31%(-41.8%) | -149.48%(-44.0%) |
| Sep 2022 | - | -267.05%(+31.0%) |
| Jun 2022 | - | -203.90%(-17.2%) |
| Mar 2022 | - | -246.31%(+3.8%) |
| Dec 2021 | -353.06%(-80.2%) | -237.40%(-35.5%) |
| Sep 2021 | - | -368.31%(-1.5%) |
| Jun 2021 | - | -374.05%(-28.9%) |
| Mar 2021 | - | -526.45%(-24.8%) |
| Dec 2020 | -1782.46%(-95.5%) | -700.34%(-65.2%) |
| Sep 2020 | - | -2011.16%(-89.5%) |
| Jun 2020 | - | -19.10 K%(-81.8%) |
| Mar 2020 | - | -105.10 K%(+102.6%) |
| Dec 2019 | -39.82 K%(+941.1%) | -51.88 K%(-43.9%) |
| Sep 2019 | - | -92.48 K%(+601.9%) |
| Mar 2019 | - | -13.18 K%(+67.1%) |
| Dec 2018 | -3824.99% | -7885.63%(+453.7%) |
| Sep 2018 | - | -1424.26%(-72.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -5090.23%(-72.5%) |
| Mar 2018 | - | -18.48 K%(-79.2%) |
| Dec 2017 | -44.85 K%(+70.0%) | -88.79 K%(+116.8%) |
| Sep 2017 | - | -40.95 K%(+14.4%) |
| Jun 2017 | - | -35.79 K%(-0.9%) |
| Mar 2017 | - | -36.12 K%(+38.5%) |
| Dec 2016 | -26.39 K%(+9.5%) | -26.07 K%(+10.3%) |
| Sep 2016 | - | -23.63 K%(-19.9%) |
| Jun 2016 | - | -29.51 K%(+12.1%) |
| Mar 2016 | - | -26.33 K%(-9.4%) |
| Dec 2015 | -24.11 K%(+77.4%) | -29.05 K%(+16.1%) |
| Sep 2015 | - | -25.02 K%(+13.1%) |
| Jun 2015 | - | -22.12 K%(+9.3%) |
| Mar 2015 | - | -20.23 K%(+9.6%) |
| Dec 2014 | -13.59 K%(+119.4%) | -18.46 K%(+0.2%) |
| Sep 2014 | - | -18.43 K%(+7.2%) |
| Jun 2014 | - | -17.19 K%(+136.5%) |
| Mar 2014 | - | -7269.62%(+151.5%) |
| Dec 2013 | -6195.30%(+2.9%) | -2890.94%(-44.8%) |
| Sep 2013 | - | -5232.91%(-65.4%) |
| Jun 2013 | - | -15.13 K%(+17.3%) |
| Mar 2013 | - | -12.90 K%(-17.8%) |
| Dec 2012 | -6023.15%(+20.9%) | -15.71 K% |
| Dec 2011 | -4979.89% | - |
FAQ
- What is Revance Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Revance Therapeutics?
- What is Revance Therapeutics annual operating margin year-on-year change?
- What is Revance Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Revance Therapeutics?
- What is Revance Therapeutics quarterly operating margin year-on-year change?
What is Revance Therapeutics annual operating profit margin?
The current annual operating margin of RVNC is -95.00%
What is the all time high annual operating margin for Revance Therapeutics?
Revance Therapeutics all-time high annual operating profit margin is -95.00%
What is Revance Therapeutics annual operating margin year-on-year change?
Over the past year, RVNC annual operating profit margin has changed by +110.31% (+53.73%)
What is Revance Therapeutics quarterly operating profit margin?
The current quarterly operating margin of RVNC is -53.87%
What is the all time high quarterly operating margin for Revance Therapeutics?
Revance Therapeutics all-time high quarterly operating profit margin is -52.79%
What is Revance Therapeutics quarterly operating margin year-on-year change?
Over the past year, RVNC quarterly operating profit margin has changed by +15.55% (+22.40%)